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Background: Foot symptoms in rheumatoid arthritis (RA) derive from a combination of inflammation, altered
foot mechanics, deformity and secondary skin lesions. Guidelines recommend regular review of patients’ feet,
but the extent to which the general population of RA patients report foot symptoms and access foot care has not been
established. The aims of this study were to determine the prevalence, impact and care of foot problems in all patients
with RA in one geographical area and identify factors associated with accessing foot care.
Methods: Cross-sectional survey of a random sample of patients with RA, who resided within a single community-based
National Health Service (NHS) podiatry service. The questionnaire collected demographic data (age, gender,
local deprivation score), clinical data (disease duration, arthritis medications, disability (Health Assessment
Questionnaire (HAQ)), current foot problems, foot care accessed (podiatry, orthotics and/or orthopaedics) and
care received, measures of impact (Foot Impact Scale) and ability to work.
Results: Of 1003 total eligible patients in the target population, 739 were posted survey packs. Of these 413
(56%) replied. Responders and non-responders had similar age (63.5 yr. vs.61.5 yr), gender (74.1%F vs. 75.2%F),
and highest deprivation category (13.3% vs.15.9%). Of the responders 92.1% reported current foot problems:
articular 73.8%, cutaneous lesions 65.4%, structural 57.6%, extra-articular 42.6%. Responders’ median (IQR)
disease duration 10 (5–20) years, HAQ 1.5 (0.75–2.0), FISIF 10 (6–14) and FISAP 16 (7–23) and 37.8% reported
impacts on work. While 69.5% had accessed foot care there were differences in the route of access (by
gender and whether independent or NHS provision) and were older (64.9 yr. vs 60.4 yr. p = 0.001), had longer
disease duration (12 yr. vs 7 yr. p < 0.001) and had a greater proportion of females (72.2% vs 61.7% p = 0.04)
than those who had not accessed care.
Conclusions: Current foot problems were reported by 92.1% of the study sample and substantially impacted
on life and work. While overall access to foot care was higher than anticipated, routes of access differed
and extent of current problems suggests the provision of effective, timely and targeted care is a pressing need.
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Foot involvement is so common in early rheumatoid arth-
ritis (RA) that it is part of the well-described clinical pic-
ture at presentation [1]. Continuing foot involvement in
patients with longstanding RA has been estimated as 30%
to 90% [2–4] but no formal survey has been reported in a
random selection of a geographically defined RA popula-
tion. Clinical issues involving the feet include articular fea-
tures such as joint pain, stiffness and swelling; extra-
articular features such as bursae, nodules and numbness;
structural deformities such as hallux valgus and toe de-
formities; and cutaneous lesions such as callosities, nail
pathologies and ulceration [4–7]. Foot problems can lead
to reduced walking distance, impaired health-related qual-
ity of life and an increased risk of falls [8–10]. Despite re-
cent advances in the medical management of RA,
prospective longitudinal studies report that even in pa-
tients classified as being in remission, up to 40% have con-
tinuing disease features in the feet [2, 11]. Although
national guidelines and expert opinion call for timely and
appropriate foot care [12–14], provision of dedicated foot
care services for inflammatory arthritis is variable and ser-
vice provision has been reported to be poor [15–17]. Fur-
thermore, the non-pharmacological management of foot
problems in patients with RA can involve a variety of in-
terventions such as treatment for cutaneous lesions,
provision of foot orthoses, prescribed footwear and ortho-
paedic surgery. These treatments can be delivered by a
variety of clinicians within both primary (community) and
secondary (hospital) care settings such as podiatrists, or-
thotists and orthopaedic surgeons. Additionally, foot care
in the UK can be provided within the National Health Ser-
vice (NHS) and independent health care sector (outside
NHS provision). Overall access to and utilisation of foot
care services is reported to be relatively low compared to
foot health care needs and inequitable, being more likely
to be taken up by affluent older women [18–20].
However, the evidence base quantifying the prevalence
of foot problems and access to foot care in patients with
RA has uncertainty, as it rests on observational hospital-
based studies using convenience sampling strategies or
surveys of self-selecting groups using restricted outcome
measures [4, 6, 21]. Although these studies have provided
valuable insights their findings cannot be extrapolated to
the general RA population. Furthermore, they may not ac-
count for regional variation of foot care service provision
for patients with RA [15]. In addition, the clinical features
of foot problems in RA and a description of care received
have not been documented in detail.
In order to establish the prevalence and impact of foot
problems and access to foot care in patients with RA a sur-
vey is required of a large group of patients with RA, ran-
domly selected from a defined population which has
equitable access to both primary and secondary based footcare services and including assessment of the full range of
impact. Here we report such a survey using an RA
population-based sample in a well-defined geographical
area to determine the prevalence of self-reported foot prob-
lems, assess their impact (based on previous qualitative
work [22], identify the proportion of patients who have
accessed foot care (podiatry, orthotics and/or orthopaedics)
within the study geographical area.
Methods
Study population
The study design was an RA population-based, cross-
sectional survey of patients conducted in Bristol, United
Kingdom. Bristol has a mixed population with a broad
range of social affluence and deprivation [23]. Rheuma-
tology services for the city of Bristol and surrounding
areas are provided by two NHS hospitals with rheuma-
tology services and long-term follow-up of RA patients
similar to those in other parts of England [24]. NHS or-
thotics and orthopaedic services are provided at both
hospitals. A single community-based service provides
NHS podiatry care to a well-defined local population
based on their registration with primary care general
practices all of which feed into one or both hospitals.
The general practices are within the geographical
boundary of the Bristol Clinical Commissioning Group
(CCG) which is responsible for NHS services for the city
of Bristol. The target population for this study was
patients diagnosed with RA [25] attending for rheuma-
tology medical care at either hospital, over the age of
18 years, and registered for primary care within the
community service geographical boundary. Thus the tar-
get population was all adult patients with a consultant
diagnosis of RA residing within the Bristol CCG geo-
graphical area. Hospital databases were accessed to
facilitate identification of patients within the target
population. Within the study geographical area patients
are universally diagnosed with RA in specialist care
(hospital based consultants). As the hospital databases
cannot select on geographical area, patient details were
reviewed to ensure they were within the defined com-
munity service boundary. A total of 2335 patients were
registered for rheumatology medical care at the two hos-
pital sites. Of these, 1003 RA patients (target population)
were within the community service geographical bound-
ary and therefore met the study eligibility criteria.
The study subjects were selected by random sampling
from departmental databases of the target population at
both hospitals. Patients were sent an invitation letter, a
questionnaire and a FREEPOST return envelope. If no re-
sponse was received within 3 weeks this was repeated. If
any patients had a pending rheumatology appointment
within the next month, they were not contacted until after
that appointment. This was to reduce the potential for the
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imminent consultation, and thus alter the response to the
survey on discussions about feet during consultations.
The sample size requirements for this study were difficult
to estimate as the extent of variation in access to foot care
(and possibly foot care needs) was unknown a priori. Based
on existing published rates [4, 20, 21] the chosen target of
400 patients would enable the proportion of patients
reporting foot problems or with specialist foot care need or
history to be estimated with a margin of error not greater
than 5 percentage points and confidence limits of at least
95%.The chosen target was also based on the expectation
that there would be a maximum of 5 to 6 main determi-
nants of access to foot care, which would be identified by
multivariate analyses with adequate precision [26]. Ques-
tionnaires were distributed to RA patients in randomly as-
sembled batches and this continued until the number of
questionnaires returned reached the chosen target of 400
returned response sets. Research ethics committee approval
was obtained (Central Bristol Medical Research Ethics
Committee, 11/SW/0327) and informed consent was in-
ferred by the return of completed questionnaires.
Study questionnaire
The study questionnaire collected clinical and general
demographic data, presence and impact of foot prob-
lems, foot care accessed and a description of foot care
received. Responders were classified as having accessed
foot care (AFC) if they reported to have accessed/utilised
podiatry, orthotics and/or orthopaedics. Conversely, re-
sponders who had not accessed any of the defined foot
care services were classified as not accessed foot care
(NAFC). The content of the questionnaire was devel-
oped from data generated from one-to-one interviews
with patients with self-reported foot problems [22], a
narrative review of the literature in relation to studies
reporting foot problems [27], validated questionnaires
measuring the impact of foot problems in RA (Foot Im-
pact Scale (FIS)) [28], and a measure of general disability
(Health Assessment Questionnaire (HAQ)) [29, 30]. A
convenience sample of 10 patients commented on the
content of the study materials and provided valuable
feedback to inform the final format of the questionnaire.
Scoring the scales
The FIS comprises two subscales, FIS Impairment / Foot-
wear (FISIF) and FIS Activities / Participation (FISAP).
FISIF scores ≤ 6 are considered mild, 7–13 moderate and
≥ 14 severe measures of foot related impairment. FISAP
scores ≤ 9 mild, 10–19 moderate and ≥ 20 severe are con-
sidered for measurements of activity limitation [5]. Full
guidance on the scoring of the FIS (for example how to
deal with missing data) has not been published; a pre-
determined, pragmatic approach was therefore required inrelation to scoring the scale. For this study a minimum of
90% of all questions had to be completed for the scores to
be admissible (FISIF > 18 and FISAP > 27 questions com-
pleted). Missing values were given the average of the indi-
vidual patient’s score for the other questions. If any
returned FIS questionnaires were not sufficiently com-
pleted to meet the defined admissible criteria, the incom-
plete FIS scores were excluded from analysis. HAQ scores
were admissible if there was at least one response in at
least 7 sections and the missing section was given the
average score of the individual patient’s score for the other
sections [29].Social deprivation
The Index of Multiple Deprivation (IMD) 2007 for
England was used as a measure of local deprivation.
IMD scores were obtained from postcodes utilising
GEOConvert software (http://geoconvert.mimas.ac.uk,
accessed 09/10/13). IMD scores were taken for the
whole study sample and were converted into categor-
ies. Category 1 of least deprived (most affluent) was
defined as the lowest 20% of numerical scores recorded
in the study, Category 2 represents the second fifth
(21%- 40%), and up to category 5 most deprived (least
affluent (81–100%). These categories are therefore an
index of comparative local deprivation within the study
sample [31].Statistical analysis
Descriptive statistics were used to characterise the study
sample. Continuous variable data were expressed either
as means, standard deviations (SD) or as medians with
their inter-quartile range (IQR), depending on the
underlying distribution. For categorical data, proportions
were calculated and expressed as percentages.
Univariate analyses were conducted to compare the
general and clinical characteristics of responders who
accessed foot care (AFC) and responders who had not
accessed foot care (NAFC) since being diagnosed with
RA. Continuous variable data were expressed either as
means, standard deviations (SD) and compared using
independent sample t-tests, or as medians with their
inter-quartile range (IQR) and compared using the
Mann-Whitney U test, depending on the underlying
distribution. For categorical data, proportions were cal-
culated and expressed as percentages and, where appro-
priate, compared using the Chi-squared test applied to
the original numbers. P values < 0.05 were considered
statistically significant.
Multivariate analyses were undertaken to determine
the statistical significance of contributory factors as in-
dependent variables influencing access to foot care
(AFC/NAFC) as the dependent variable. Binary logistic
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analyses. Initial selection of the independent variables in-
cluded in the logistic regression model was conducted
after univariate analyses identifying differences (non-foot
related) between the AFC group and the NAFC group
(NAFC). Logistic regression analyses were then per-
formed to assess the predictive ability of each inde-
pendent variable by controlling for the effects of the
other independent variables in the model. Analyses
were conducted utilising binary entry (block entry)
whereby all the independent variables were entered in
to the model simultaneously. Incomplete data sets
(missing data) were excluded from logistic regression
analyses using case pairwise deletion. Predictor vari-
ables associated with the outcome with p ≤ 0.05 were
selected as variables in a series of logistic regression
models. The statistical analyses were conducted using
SPSS 19.0 (SPSS Inc. Chicago, Illinois).Site 1 patients 
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Accessed hospital data
patient
Total pa
(target po
n=10
Postal survey packs
sample of the target 
Responders 1st invitation
n=295
Site 1 patient
population
Total admi
analysis n=4
Total ret
n=415 (5
Fig. 1 Flow diagram of study recruitmentResults
Participants
Of the 1003 patients, within the target population, 739
were posted a questionnaire before the target sample
size was achieved and 415 returned. Of these 295 were
returned directly and 120 after a reminder, giving an
overall response rate of 56.2% (Fig. 1). Two returned sur-
veys were inadmissible due to large quantities of missing
data and 413 were available for analysis.
Some information was available on the 324 non-
responder study subjects in relation to gender, age, local
deprivation scores and hospital site. The characteristics of
the responders and non-responders to the questionnaire
are summarised in Table 1. Responders were slightly
younger than non-responders (63.5 years v 61.5 years) but
a similar proportion were male (25.9% responders v 25.3%
non-responders). There was only a small difference in
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Table 1 Response rates general characteristics
Target population
(n = 739)
Responders
(n = 413)
Non-responders
(n = 324)
Female number (%) 552 (74.7) 306 (74.1) 246 (75.9)
Age mean years (SD) 62.6 (13.6) 63.5 (12.8) 61.5 (14.6)
Social deprivation (IMD LSOA categories)a
Number (%)
1 (least deprived) 179 (24.2) 116 (28.1) 63 (19.4)
2 290 (39.2) 143 (34.6) 147 (45.4)
3 163 (22.1) 99 (24.0) 64 (19.8)
4 66 (8.9) 36 (8.7) 30 (9.3)
5 (most deprived) 41 (5.5) 19 (4.6) 22 (6.8)
Site 2 (%) 385 (52.1) 204 (49.4) 181 (55.8)
aIMD scores converted into categories
Table 2 Clinical characteristics responders
Demographic and clinical characteristics responders (n = 413)
Disease duration median
years (IQR)
10 (5 to 20)
Age at diagnosis mean
years (SD)
50.3 (14.9)
Arthritis medications
number (%)
NSAIDs 128 (31.0)
DMARDs 339 (82.1)
Glucocorticoids 122 (29.5)
Biologics 74 (17.9)
HAQ median score (IQR)b 1.5 (0.75 to 2.0)
FIS median score (IQR)a b FISIF 10 (6 to 14)
FISAP 16 (7 to 23)
Importance median
score (IQR)a
6 (3 to 8)
Cope median score (IQR)a 5 (3 to 7)
Severity median score (IQR)a 6 (3 to 8)
Impact of foot problems on
ability to work number (%)
Yes 156 (37.8)
No 98 (23.7)
Not applicable 159 (38.5)
Time interval of last recalled
foot examination number (%)b
0–6 months 89 (21.6)
> 6–12 months 61 (14.8)
> 12–18 months 34 (8.3)
> 18 months 97 (23.5)
Can’t remember 31 (7.5)
Never had
feet examined
100 (24.3)
aFISIF Foot Impact Score foot impairment/ footwear restriction subscale,
FISAP FIS activity limitation/participation restriction subscale;
Importance = importance of foot problems; Cope = ability to cope with
foot problems; Severity = severity of foot problems
bHAQ admissible n = 404; FIS admissible n = 400; foot examination admissible
n = 412; IQR = Interquartile range
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similar for both hospital sites. Responders were conse-
quently regarded as being adequately representative of the
target RA population in the analyses.
Clinical characteristics responders
A wide range of disease duration and current disability
was reported (Table 2). The majority of responders were
taking medications for their RA (n = 394, 95.4%) and one
half was taking more than one category of arthritis
medication (n = 210, 50.8%). Impact of foot problems
was substantial with 178 (44.5%) reporting moderate
foot related impairment and 105 (26.3%) reporting se-
vere foot related impairment (FISIF). The impact of foot
problems in relation to activity levels and participation
in valued activates (FISAP) was 110 for moderate impact
(27.5%) and 161 (40.3%) for severe. Of the 413 re-
sponders 254 (61.5%) were working, of these 156 (61.4%)
reported foot problems impacting on their ability to
work. The majority (n = 312, 75.7%) of responders re-
ported having had a foot examination.
Almost all respondents reported they had experienced
foot problems at some time being diagnosed with RA
(Table 3). The majority of responders (n = 377, 91.2%) re-
ported the presence of one or more foot problems currently
and over half reported (n = 215, 52.1%) 5 or more foot
problems. The rates of current foot problems in women
and men were similar (n = 279, 90.0% v n = 91, 85.8%).
Of the 413 responders, 287 (69.5%), had accessed foot
care (AFC) and 140 (48.8%) had accessed two or more ser-
vices. The general, clinical and foot related characteristics
of the AFC group and the NAFC group are presented in
Additional file 1 (online). Overall the AFC group were
slightly older and had longer disease duration than the
NAFC group (64.9 years v 60.4 years, p = 0.01; 12 years v
7 years, p < 0.001). Additionally a higher proportion of fe-
males had accessed foot care compared to males (F 72.2%
v M 61.7% p = 0.04). The proportions from more deprived
areas (IMD score categories 3, 4 and 5) were similar for
both groups (AFC 36.2% v NAFC 39.7% p = 0.363).Although disability was statistically significant in univar-
iate analyses (AFC 1.62 v NAFC 1.12 p = 0.005), HAQ
scores included lower limb disability and these were there-
fore omitted from multivariate analyses. As an assumption
of logistic regression analyses requires independent
Table 3 Reported foot problemsa
Category Foot problem Current Ever Never
Articular features Pain 263 (63.7) 342 (82.8) 71 (17.2)
Stiffness 224 (54.2) 277 (67.1) 73 (17.8)
Swelling 218 (52.8) 286 (69.2) 127 (30.8)
Any articular feature 305 (73.8) 373 (90.3) 40 (9.7)
Cutaneous lesions Blisters 28 (6.8) 73 (17.7) 340 (82.3)
Callus 171 (41.4) 206 (49.9) 297 (50.1)
Corns 72 (17.4) 109 (26.4) 304 (73.6)
In-grown toe nails 59 (14.3) 106 (25.7) 307 (74.3)
Thickened Toe nails 168 (40.7) 190 (46.0) 223 (54.0)
Ulcers 13 (3.1) 38 (9.2) 375 (90.8)
Any cutaneous lesions 270 (65.4) 303 (73.4) 110 (26.6)
Structural deformity Bunions 111 (26.9) 141 (34.1) 272 (65.9)
Fallen arches 93.(22.5) 121 (29.3) 292 (70.7)
Misshaped toes 180 (43.6) 199 (48.2) 214 (51.8)
Any structural deformity 238 (57.6) 265 (64.2) 148 (35.8)
Extra-articular features Nodules 96 (23.2) 122 (29.5) 291 (70.5)
Numbness 118 (28.6) 153 (37.0) 260 (63.0)
Any extra articular feature 176 (42.6) 212 (51.3) 201 (48.7)
Other Infection 31 (7.5) 76 (18.4) 337 (81.6)
Any foot problems 377 (91.2) 403 (97.6) 10 (2.4)
a(n = 413 (%))
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interest [32]. Logistic regression analyses revealed in-
creased odds (OR) of AFC in those with longer disease
duration (OR = 1.04, 95% CI 1.02–1.07) and in those who
were older (OR = 1.02, 95% CI 1.01–1.04). Although these
results demonstrate disease duration and age to be inde-
pendent factors of access to foot care the effect for both
was mild. The strongest predictor of AFC was femaleTable 4 Independent variables determinants AFC (n = 413)
Predictive variable Univariate analysesa Mu
Hospital site Proportions similar AFC versus
NAFC according to hospital site
Exc
Gender p = 0.04 Inc
Age p = 0.01 Inc
Social deprivation p = 0.363 Exc
Disease duration p= > 0.001 Inc
Arthritis medications Proportions similar AFC versus
NAFC according to arthritis
medications
Exc
Disability (HAQ) p = 0.005 Exc
cap
aUnivariate analyses of demographic and clinical variables to identify factors associa
bVariables with p = < 0.2 in univariate analyses were entered into a series of logistic
predictors of AFC
cCI 95% Confidence Intervalgender, with an odds ratio of 1.72 (95% CI 1.06–2.88). So-
cial deprivation did not make a statistically significant
contribution to the model (OR 0.87, 95% CI 0.70–1.09).
Table 4 presents the results of univariate and logistic re-
gression analyses.
The AFC group reported a wide range of foot care re-
ceived (Table 5). Device prescriptions were the most fre-
quent care category reported. Of the 72 patients wholtivariate analysesb Exp (B)
Adjusted odds
ratio (CI 95%)c
p
luded from model
luded in model 1.72 (1.06–2.88) 0.03
luded in model 1.02 (1.00–1.04) 0.02
luded from model
luded in model 1.04 (1.02–1.07) < 0.01
luded from model
lude from model, as 1 section
tures lower limb disability
ted as predictors of AFC
regression models to identify independent
Table 5 Foot care interventions received
Foot care category Foot care
interventions
AFC (n = 287)a
Number (%)
Devices Hospital shoes 73 (25.4)
Insoles 190 (66.2)
Padding 58 (20.2)
Toe protectors 11 (3.8)
Any devices 222 (76.4)
Non-pharmacological Advice 69 (24.0)
Foot exercises 42 (14.6)
Any non-pharmacological 93 (32.4)
Pharmacological Antibiotics for infection 24 (8.4)
Creams for infection 22 (7.7)
Steroid injection 40 (13.9)
Any pharmacological 74 (25.8)
Treatment
cutaneous lesion
Nail care 53 (18.5)
Treatment for corn/callus 62 (21.6)
Wound care 19 (6.7)
Any treatment
cutaneous lesions
99 (34.5)
Other Foot surgery 72 (25.1)
aMissing data 9 (3.1%) AFC group
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foot problems had improved after surgical intervention.
Of the AFC group, 204 (71.1%) had accessed podiatry
(NHS and/or independent sector), 192 (66.7%) orthotics
and 92 (32.1%) orthopaedics and 140 (48.8%) had
accessed two or more services (Table 6). Over half of the
podiatry group had accessed independent sector podiatry
care (with or without NHS care) (n = 107, 52.5%). No in-
formation was available on exclusive use of independent
sector care. Of the patients who had accessed podiatry,
nearly half (n = 95, 46.5%) had self-referred including 39
(19.1%) who had accessed independent sector foot care
(i.e. outside the NHS). There were differences in accessTable 6 Gender and routes of access to foot care servicesa
Referral route Podiatry (n = 204)
(Number (%)
O
N
Female
n = 158 (77.5)
Male
n = 46 (22.5)
Fe
n
Self Any podiatry 47 (29.7) 9 (20.0) 3
Independent 30 (19.0) 9 (20.0) 2
GP 35 (22.2) 19 (41.3) 1
Hospital 42 (26.6) 8 (17.4) 1
Community nurse 2 (1.3) 0 (0) 0
Other 2 (1.3) 1 (2.2) 1
Missing data 0 (0) 0 (0) 1
a ≥ 2 services accessedroutes for each service according to gender. Women
were more likely than men to access podiatry (NHS and/
or independent sector) care through self-referral (29.7%
v 20.0%) and from hospital clinicians (26.6% v 17.4%)
whereas men were more likely to be referred by their
GP (41.3% v 22.2%). The proportions of patients self-
referring for independent sector podiatry care was simi-
lar for both genders. In contrast the proportion of
women referred to orthopaedics by hospital based clini-
cians was higher than GP initiated referrals (F 71.4% v F
20.7%). Access routes to orthotics were broadly similar
for gender.
Discussion
This study achieved an overall response rate of 56%,
similar to other postal surveys of patients with RA
conducted in the UK [4, 33]. Responders and non-
responders were similar in relation to hospital site, gen-
der, age; and social deprivation. Additionally the general
and RA characteristics of responders were similar to
other postal surveys of patients with RA conducted in
the UK [7, 33–35]. Thus the responders to this survey
are likely to represent the target population, and the tar-
get population may reflect the general diagnosed RA
population.
These results show that patients with RA in this study
experience a wide range of foot problems and the great
majority currently have one or more foot problems. The
prevalence of foot pain, numbness and ulceration re-
ported in this study were broadly similar to but slightly
lower than earlier surveys based on selected populations
[4, 7]. However, this study provides the broadest descrip-
tion of foot problems reported in a random sample of a
defined population of patients with RA to date.
Foot impact scores were slightly lower than previous
studies [5, 36, 37]. However, these data represent the
overall impact of foot problems of all patients with RA
in a defined geographical area as opposed to selected
samples such as patients attending a specific clinic. Therthotics (n = 192)
umber (%)
Orthopaedics (n = 92)
Number (%)
male
= 151 (78.6)
Male
n = 41 (23.4)
Female
n = 77 (83.7)
Male
n = 15 (16.3)
(2.0) 0 (0) 1 (1.3) 0 (0)
(1.3) 0 (0) 2 (2.6) 1 (6.7)
9 (12.6) 6(14.6) 16 (20.7) 9 (60.7)
26 (83.4) 33 (80.2) 55 (71.4) 5 (33.3)
(0) 0 (0) 1 (1.3) 0 (0)
(0.7) 2 (1.0) 2 (2.6) 0 (0)
(0.7) 0 (0) 0 (0) 0 (0)
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lems to be considerable in a wide population sample of
patients with RA. However, the findings of an earlier
qualitative study indicated not all issues of the impact of
foot problems (e.g. work related disability) are captured in
the FIS [28]. Work related disability in patients with RA
has been widely described [38–40] and this study provides
new insights identifying the specific and substantial im-
pact of foot problems on work related disability.
An annual review of patients’ feet and access to foot
care services is recommended in national guidelines
[12]. However, surveys of rheumatology departments
have shown the provision of dedicated foot care ser-
vices for patients with inflammatory arthritis is variable
[15–17]. Additionally, the conduct of foot examinations
in clinical practice can also be variable as the foot is
omitted from standard measures of disease activity such
as the Disease Activity Score [41] and consequently
foot problems may be ignored in clinical consultations
[2, 11]. The majority of responders in this study
recalled having undergone a foot examination, although
only a third reported to having had a foot examination
in the preceding 12 months. The accuracy of patients
recalling the time when foot examinations were con-
ducted can be questioned. Nonetheless this study sug-
gests patients perceive the time interval of when foot
examinations were conducted to be variable and poten-
tially not complying with national guidelines [12].
Based a review of the literature and local service evalu-
ation, it was estimated that many patients within the
study geographical area would not have accessed foot
care. However, the proportion of patients who had
accessed foot care was higher than anticipated. It is pos-
sible repeated interactions with clinicians may overcome
barriers to utilisation of health care services and thus pa-
tients with RA may be more likely to access additional
services including foot care. Indeed patients with RA
being regular users of health care provided by a wide
range of clinicians has been reported [42]. However, ac-
cess to and utilisation of health care services in general
terms is complex. A number of predisposing factors such
as general characteristics (age, gender, social deprivation),
clinical characteristics (type of health condition acute or
long term, additional morbidity) experience and satisfac-
tion of care received are reported to influence individuals
in their decisions to access health care or not [43]. Fur-
thermore, patients’ reasons for accessing and utilising foot
care services are complex [22]. In spite of the higher than
expected access rates, many patients from both the AFC
group and NAFC group reported current foot problems.
The proportion of patients who had accessed podiatry was
similar to an earlier postal survey of patients with RA [4].
However, in a longitudinal cohort study of patients with
early RA, only 30% of study participants reported to haveaccessed podiatry and 4% orthopaedics [20]. This may be
accounted for by the differences between this random
RA-population sample compared to an early arthritis
cohort.
In multivariate analyses age and disease duration were
independently associated with having accessed foot care,
but not strongly. Foot problems are reported to affect
one in four older people [44]. It therefore is possible to
postulate patients with RA who are older and have lon-
ger disease duration are more likely to develop foot
problems and therefore seek foot care. However, severity
and clinical progression of RA varies from patient to pa-
tient. Thus the mild influence of age and disease dur-
ation as possible determinants of accessing foot care
would seem reasonable. Female gender was the strongest
independent predictor of AFC. This is not an unex-
pected result as it has been reported foot problems may
be more prevalent in women [45, 46], and utilisation of
health care has been widely reported to be higher in
women [47–49]. This study has identified broad charac-
teristics of which patients are likely to access foot care in
in Bristol, UK. For example women were more likely to
self-refer and men more likely to be advised by clinicians
to seek treatment. Knowing that female patients are more
likely to access foot care does not necessarily reflect
greater clinical need.
In the UK, podiatry services are provided within both
the NHS and independent health care sectors. Of the
responders who had accessed podiatry services one
half reported to have accessed independent sector foot
care. A recent UK based survey of 217 patients with
RA who had accessed podiatry care showed that the
majority (76%) had used independent sector care [21].
It could be inferred that patients consider their foot
problems to be an important health care need that they
are willing to self-fund. Conversely, patients may elect
to self-fund their foot care due to lack of NHS pro-
vided foot care, barriers to accessing care and/or ex-
perience of care received [22].
Of the AFC group, a range of care interventions was
reported. Foot care “devices” was the most common care
category reported suggesting clinicians consider them
beneficial. However, despite having accessed foot care,
the majority of patients reported current foot problems
and substantial impact. These data therefore raise ques-
tions regarding effectiveness and/or continuity of foot
care received. However, data in relation to the clinical
significance of foot problems at the time foot care was
accessed is not available. Firm conclusions regarding the
effectiveness of foot care received cannot be drawn dir-
ectly from these data, as that would require contempor-
aneous clinical examination of the feet.
The number of podiatrists within the independent
sector specialising in inflammatory arthritis within the
Wilson et al. Journal of Foot and Ankle Research  (2017) 10:46 Page 9 of 11geographical area of this study is unknown. However,
non-specialists’ knowledge of national guidelines for the
management of foot problems in rheumatic diseases
shows wide variation [50]. In order for patients to receive
timely and effective care non-specialist clinicians need to
have the clinical skills to identify and refer patients who
require specialist review. The role of specialist podiatrists
as members of hospital based multidisciplinary teams’
managing diabetic foot disease is well established in the
UK [51]. In contrast, the number of podiatrists as mem-
bers of rheumatology multidisciplinary teams in the UK
is variable [15]. Provision of foot care services for pa-
tients with RA could reflect the diabetes model. Indeed
close collaboration between clinicians for access and
management of foot problems in RA has long been
advocated [52].
Overall, this study has provided data in relation to: (i)
a description of the general and RA characteristics of a
large random sample of all RA patients residing within a
defined geographical area; (ii) estimated the reported
prevalence and impact of current foot problems; (iii)
identified the proportion of patients who have accessed
foot care services; (iv) provided a description of foot care
patients received. These data are from a community
based random sample of all patients with RA in a defined
geographical area. How and whether or not patients in the
general RA population access foot care may be variable
and potentially influenced by different patterns of foot
care service provision. How these data reflect the situation
in other geographical areas could be the focus of further
investigation.
Strengths and limitations
Is a strength of this study that the patient population
was a random sample of all patients within a defined
geographical area, the sample size was large and re-
sponders were an accurate representation of the target
population of adult patients with RA. Additionally, al-
most all the returned questionnaires were admissible
(minimal missing data), indicating patients found the
survey items easy to understand and complete. There
are some limitations to this study. While the prevalence
of one or more current foot problems in patients with
RA by self-report was very high, it would be useful to
know to what extent patient self-report is accurate. The
clinical categorisation of foot problems and the propor-
tion of patients who might benefit from immediate foot
care could be identified by direct clinical examination of
the feet. Data relating to the prevalence of foot problems
in non-responders is not known and there is potential
for non-responder bias. However, in this study the gen-
eral characteristics of responders and non-responders
that might cause such bias, such as the proportions of
responders from areas of deprivation, were very similar.Conclusion
Self-reported foot problems were present in 91% of a ran-
dom sample all of adult patients with RA in Bristol and
they substantially impacted on patients’ lives. Additionally
foot problems were important issues for patients. While
overall access to foot care was higher than anticipated, the
extent of current problems suggests that the provision of
effective, timely and targeted care a pressing need.
Clinicians need to have the clinical expertise in foot as-
sessments and knowledgeable of the clinical management
of foot problems. Additionally foot care needs to be co-
ordinated and tailored to individual patient’s needs in
order to improve outcomes for patients.
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